REQUEST A DEMO
Total
USD $0.00
Search more companies

Aptheco Pharmaceuticals Spolka Z Ograniczona Odpiowiedzialnoscia (Poland)

Main Activities: Department Stores
Full name: Aptheco Pharmaceuticals Spolka Z Ograniczona Odpiowiedzialnoscia Profile Updated: January 31, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Aptheco Pharmaceuticals Spolka Z Ograniczona Odpiowiedzialnoscia is based in Poland, with the head office in Wroclaw. The enterprise currently operates in the Department Stores sector. The company was established on March 26, 2015. In 2022, the company reported a net sales revenue increase of 38.92%. Its total assets grew by 54.37% over the same period. In, 2022, the company’s net profit margin increased by 27.07%.

Headquarters
Ul. Pl. Solny 15
Wroclaw; Dolnoslaskie; Postal Code: 50-950

Contact Details: Purchase the Aptheco Pharmaceuticals Spolka Z Ograniczona Odpiowiedzialnoscia report to view the information.

Basic Information
Outstanding Shares:
Purchase the Aptheco Pharmaceuticals Spolka Z Ograniczona Odpiowiedzialnoscia report to view the information.
Registered Capital:
Purchase the Aptheco Pharmaceuticals Spolka Z Ograniczona Odpiowiedzialnoscia report to view the information.
Incorporation Date:
March 26, 2015
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
99%
Subsidiaries
Aptheco Pharmaceuticals Sp. z o.o. &Wspolnicy
Aptheco Pharmaceuticals Sp. z o.o. I Wspolnicy sp. j.
Company Performance
Financial values in the chart are available after Aptheco Pharmaceuticals Spolka Z Ograniczona Odpiowiedzialnoscia report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
38.92%
Total operating revenue
39.72%
Operating profit (EBIT)
4164.68%
EBITDA
1025.74%
Net Profit (Loss) for the Period
4164.68%
Total assets
54.37%
Total equity
66.87%
Operating Profit Margin (ROS)
27.07%
Net Profit Margin
27.07%
Return on Equity (ROE)
-200.29%
Quick Ratio
0.37%
Cash Ratio
0.61%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?